- Advanced Cell Technology (ACT) is a biotechnology company focused on developing stem cell therapy programs including retinal pigment epithelium cells for age-related macular degeneration, myoblast cells for heart disease, and hemangioblast cells for blood and circulatory disorders. - ACT has a proprietary single blastomere technology that can generate embryonic stem cell lines without destroying embryos using preimplantation genetic diagnosis. - ACT has several stem cell therapy programs in clinical trials or preclinical research stages and collaborates with major research institutions. It also has a robust stem cell patent portfolio and facilities for manufacturing.